Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
27.27
+0.63 (2.36%)
Jul 17, 2026, 12:35 PM EDT - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.43 billion as of July 17, 2026. Its market cap has increased by 249.80% in one year.
Market Cap
3.43B
Enterprise Value
2.71B
1-Year Change
249.80%
Ranking
Category
Stock Price
$27.27
ChartMarket Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.43B, an increase of 384.37%. That is a compound annual growth rate of 20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.43B | 33.30% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.85B |
| Parabilis Medicines | 3.82B |
| NewAmsterdam Pharma Company | 3.72B |
| Telix Pharmaceuticals | 3.71B |
| Enliven Therapeutics | 3.71B |
| Alumis | 3.62B |
| Denali Therapeutics | 3.61B |
| Structure Therapeutics | 3.51B |